Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Some supplements and hormones can increase hair loss by raising DHT levels.

Jagged1 and Epidermal Growth Factor together significantly increased hair growth in mice with androgen-suppressed hair.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Baldness caused by male hormones in female-to-male transsexuals doesn't increase the risk of heart disease.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

Testosterone therapy helps boys with hormone deficiencies develop normal male characteristics and grow properly.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Low testosterone can cause a heart rhythm problem in men, but fixing it can prevent the issue.

Androgens like testosterone affect hair growth and oil production differently across body parts and individuals.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Muscles can make their own androgens, which may help muscle growth.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Thyroid hormones and androgens affect gene expression in frog reproductive organs differently between males and females.

Brassica oleracea extract, glucosinlates, and sulforaphane can boost hair growth and might be used to treat hair loss.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.